Evidence map›Paper›PMID 37006228›Full record

ArticleFuture science OA2023

Recurrent primary hepatic VIPoma treated with a combination of surgical resection and loco-regional therapy.

Wafa Dahmani, Sahar Nasr, Kais Maalel, Yasser Becheikh, Ahmed Tibaoui, Zainab Lajmi, Sihem Hmissa, Hanene Jaziri, Nour Elleuch, Aida Ben Slama and 3 more

Open access · goldFull text readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Future science OA, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Wafa DahmaniGastroeneterology Department, Sahloul University Hospital, 4052, Tunisia.
Sahar NasrGastroeneterology Department, Sahloul University Hospital, 4052, Tunisia.ORCID https://orcid.org/0000-0002-9831-5806
Kais MaalelRadiology Department, Sahloul University Hospital, 4052, Tunisia.
Yasser BecheikhRadiology Department, Sahloul University Hospital, 4052, Tunisia.
Ahmed TibaouiRadiology Department, Sahloul University Hospital, 4052, Tunisia.
Zainab LajmiPathology Department, Sahloul University Hospital, 4052, Tunisia.
Sihem HmissaPathology Department, Sahloul University Hospital, 4052, Tunisia.
Hanene JaziriGastroeneterology Department, Sahloul University Hospital, 4052, Tunisia.
Nour ElleuchGastroeneterology Department, Sahloul University Hospital, 4052, Tunisia.
Aida Ben SlamaGastroeneterology Department, Sahloul University Hospital, 4052, Tunisia.
Wafa Ben AmeurGastroeneterology Department, Sahloul University Hospital, 4052, Tunisia.
Mahdi KsiaaGastroeneterology Department, Sahloul University Hospital, 4052, Tunisia.
Ali JmaaGastroeneterology Department, Sahloul University Hospital, 4052, Tunisia.
Hôpital Sahloul · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vasoactive intestinal peptide (VIP) secreting tumors (VIPomas) are insidious functional neuroendocrine tumors originating mainly from pancreatic islet cells. Hepatic localization is considered exceedingly rare as only few cases have been reported in the literature. Diagnostic and therapeutic management of this tumor is still not clearly codified and therefore represents a real challenge for clinicians. Herein we report a unique case of a primary hepatic VIPoma recurrence in a female patient 22 years after curative resection. The patient had two sessions of transarterial chemoembolization. Complete symptomatic improvement was achieved since the first day after the first session. This case highlights that long-term follow-up for patients with hepatic VIPoma is mandatory as recurrence could occur several years after curative surgical treatment.

Indexed as

hepatic resectionneuroendocrine tumortransarterial chemoembolizationVipoma

Identifiers

PMID37006228
PMCPMC10051143
OpenAlexW4323663173

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read11
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.